Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Foslevodopa
(3-hydroxy-O-phosphono-L-tyrosine)
[1] Foslevodopa[1] Foslevodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
2 Levodopa
(3-Hydroxy-L-tyrosine)
[9] Carbidopa-Levodopa; DUODOPA; Inbrija; L-DOPA; Levodopa; PARCOPA; SINEMET; SINEMET CR; Stalevo[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[6] 6, 17, 90, 140, 164, 201 💬
3 Tyrosine
(L-tyrosine)
[4] Alanine; L-tyrosine; Propanoic acid; Tyrosine[1] Tyrosine (L-Tyrosine (JP18)) 💬 --[5] 6, 75, 86, 111, 298 💬